Google DeepMind has built SynthID Bio, a watermark for AI-designed proteins, and shown in wet-lab tests on protein binders that it leaves their function intact. The method hides a signature in the ...
For the field of drug development, hitting the right target with atomic precision to achieve therapeutic effect remains the core challenge. While traditional R&D pipelines are dependent on ...
Hosted on MSN
Plain-English AI produces validated drug-candidate proteins against rare disease target
The same week that Generate Biomedicines and Zealand Pharma announced a deal worth up to $1.2 billion to develop AI-designed protein therapeutics for obesity and metabolic disease, a University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results